Legal & General Group’s Arbutus Biopharma ABUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $385K | Buy |
124,486
+6,089
| +5% | +$18.8K | ﹤0.01% | 2516 |
|
|
2025
Q1 | $413K | Sell |
118,397
-296
| -0.2% | -$1.03K | ﹤0.01% | 2456 |
|
|
2024
Q4 | $388K | Sell |
118,693
-27,104
| -19% | -$88.6K | ﹤0.01% | 2548 |
|
|
2024
Q3 | $561K | Buy |
145,797
+130,549
| +856% | +$503K | ﹤0.01% | 2425 |
|
|
2024
Q2 | $47.1K | Buy |
15,248
+2,940
| +24% | +$9.09K | ﹤0.01% | 2803 |
|
|
2024
Q1 | $31.8K | Hold |
12,308
| – | – | ﹤0.01% | 2843 |
|
|
2023
Q4 | $30.8K | Hold |
12,308
| – | – | ﹤0.01% | 2888 |
|
|
2023
Q3 | $25K | Sell |
12,308
-1,749
| -12% | -$3.55K | ﹤0.01% | 2959 |
|
|
2023
Q2 | $32.3K | Buy |
14,057
+1,859
| +15% | +$4.28K | ﹤0.01% | 2948 |
|
|
2023
Q1 | $37K | Hold |
12,198
| – | – | ﹤0.01% | 2927 |
|
|
2022
Q4 | $28.4K | Hold |
12,198
| – | – | ﹤0.01% | 3068 |
|
|
2022
Q3 | $23K | Buy |
12,198
+1,732
| +17% | +$3.27K | ﹤0.01% | 3165 |
|
|
2022
Q2 | $28K | Buy |
10,466
+2,515
| +32% | +$6.73K | ﹤0.01% | 3125 |
|
|
2022
Q1 | $24K | Buy |
7,951
+1,426
| +22% | +$4.3K | ﹤0.01% | 3180 |
|
|
2021
Q4 | $25K | Hold |
6,525
| – | – | ﹤0.01% | 3196 |
|
|
2021
Q3 | $28K | Buy |
6,525
+284
| +5% | +$1.22K | ﹤0.01% | 3145 |
|
|
2021
Q2 | $19K | Buy |
+6,241
| New | +$19K | ﹤0.01% | 3305 |
|
|
2019
Q3 | – | Sell |
-5,247
| Closed | -$11K | – | 3349 |
|
|
2019
Q2 | $11K | Hold |
5,247
| – | – | ﹤0.01% | 3339 |
|
|
2019
Q1 | $19K | Sell |
5,247
-23,160
| -82% | -$83.9K | ﹤0.01% | 3104 |
|
|
2018
Q4 | $109K | Buy |
28,407
+3,867
| +16% | +$14.8K | ﹤0.01% | 2431 |
|
|
2018
Q3 | $232K | Buy |
24,540
+19,293
| +368% | +$182K | ﹤0.01% | 2304 |
|
|
2018
Q2 | $38K | Buy |
+5,247
| New | +$38K | ﹤0.01% | 2887 |
|